The Nootropics Myth: Smart Drugs That Aren’t Smart
The nootropics market — worth several billion dollars a year — sells everything from lion's mane to racetams to "focus stacks" of a dozen herbs. The pitch is that these compounds make a healthy brain work better. For most of them, the evidence in healthy adults is somewhere between thin and nonexistent.
The Healthy Brain Problem
Most positive nootropic trials are run in people with cognitive impairment — older adults with mild cognitive impairment (MCI), Alzheimer's disease, or sleep deprivation. The size of any benefit in those groups does not transfer to healthy young or middle-aged adults with normally functioning brains. A 2016 review in Evidence-Based Complementary and Alternative Medicine (Suliman 2016 PMID 27656235) catalogued the natural-nootropic literature and found that while several compounds showed benefit in impaired populations, replicated cognitive-enhancement evidence in healthy adults was largely absent. A 2024 umbrella review of dietary supplements for cognition in healthy adults reached the same conclusion (Lampousi 2024 PMID 38395036).
Nootropics ranked by actual replicated effect
The Most Overhyped Nootropics
Bacopa monnieri has genuine evidence for delayed verbal recall after 8–12 weeks of supplementation in older adults (Stough 2008; Kongkeaw 2014 PMID 24252493 — meta-analysis of 9 RCTs). It is slow-acting, not an acute focus aid, and its marketing as an instant cognitive enhancer is not supported by the data. Ginkgo biloba: the GEMS trial (DeKosky 2008 PMID 19017911) randomized 3,069 older adults to 240 mg/day or placebo for a median 6.1 years. Ginkgo did not reduce all-cause dementia or Alzheimer's incidence (HR 1.12, 95% CI 0.94–1.33). Cognitive trajectory analyses from the same cohort found no slowing of decline (Snitz 2009 PMID 20040554). Phosphatidylserine: the FDA describes its qualified health claim for cognitive function as supported by very limited and preliminary evidence; clinical evidence in healthy young adults is nearly absent. Lion's mane: positive trials are mostly in older adults with MCI; healthy-adult cognitive evidence is small and short.
What Actually Works in Healthy People
The honest short list: caffeine (the most consistent cognitive-performance compound known), L-theanine combined with caffeine for sustained attention, and creatine monohydrate for working memory under sleep deprivation or fatigue (Avgerinos 2018 PMID 29704637 — meta-analysis). Sleep, exercise, and stress management produce cognitive effects that are an order of magnitude larger than any supplement.
Sources
- Suliman NA, et al. “Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.” Evidence-Based Complementary and Alternative Medicine, 2016;2016:4391375. PMID 27656235.
- DeKosky ST, et al. “Ginkgo biloba for Prevention of Dementia: A Randomized Controlled Trial.” JAMA, 2008;300(19):2253-2262. PMID 19017911.
- Snitz BE, et al. “Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.” JAMA, 2009;302(24):2663-2670. PMID 20040554.
- Kongkeaw C, et al. “Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.” Journal of Ethnopharmacology, 2014;151(1):528-535. PMID 24252493.
- Avgerinos KI, et al. “Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials.” Experimental Gerontology, 2018;108:166-173. PMID 29704637.
- Lampousi AM, et al. “Dietary supplements and cognitive function in healthy adults: an umbrella review.” Advances in Nutrition, 2024. PMID 38395036.
Reviewed against 6 peer-reviewed sources.